Atp5f1b Conditional Knockout mouse models

Atp5f1b is the mouse ortholog of human ATP5F1B and encodes the beta subunit, the catalytic engine of the F1 sector, contributing Walker A and Walker B nucleotide binding motifs that bind ADP and phosphate and cycle through loose, tight, and open states as gamma rotation imposes the binding change mechanism. Three beta subunits alternate with alpha subunits, and inhibitors such as aurovertin and efrapeptin act on this head, distinguishing it pharmacologically from the oligomycin sensitive membrane sector. Dominant human ATP5F1B variants have been linked to dystonia with spasticity, so a heterozygous patient knockin models the dominant biochemical lesion whereas a conditional null tests absolute requirement in a chosen lineage. No functional nuclear paralog exists, and germline ablation abolishes ATP synthesis, so plan floxed alleles with inducible Cre. Match design to endpoint, whether ATP to ADP ratio biosensors, membrane potential, striatal circuit physiology, or complex V assembly intermediates.

Tissue restricted knockout of Atp5f1b keeps wild type function everywhere else. Breeding is often more robust, and the setup mirrors patient biology where mutations arise in a subset of cells.